Drug companies join NIH in study of Alzheimer's and other diseases

Having trouble viewing this message? You may view it as a web page. You may also view e-news archives.
To prevent mailbox filters from deleting your Alzheimer's Association email communications, please add alzheimers_enews@alz.org to your address book.
February 5, 2014
24/7 Helpline: 800.272.3900
Drug companies join NIH in study of Alzheimer's and other diseases
Under a five-year collaboration, 10 drug companies and the National Institutes of Health (NIH) have agreed to share scientists, tissue and blood samples, and data. The Accelerating Medicines Project (AMP) aims to decipher the biology behind Alzheimer's disease, Type 2 diabetes, rheumatoid arthritis and lupus, and to identify targets for new drugs. The Alzheimer’s Association is involved in AMP as a steering committee member.

Click here to read more
African-Americans are at a higher risk for Alzheimer’s
February is Black History Month. African-Americans are two times more likely to develop late-onset Alzheimer's disease than whites and less likely to receive an Alzheimer’s diagnosis, which results in less time for treatment and planning. Visit our African-Americans and Alzheimer’s portal for information on warning signs, research and care, as well as stories of African-Americans who’ve furthered efforts in the fight against Alzheimer’s.
Click here to read more
Online Tools
Your Local Community
 
 
An active lifestyle using Charity Miles can benefit the Alzheimer’s Association
The Alzheimer’s Association is pleased to join Charity Miles as one of the fitness app’s charity partners. Charity Miles is a free iPhone/Android app that enables people to raise funds simply by walking, running or biking. Using the app, walkers and runners raise 25 cents per mile, and bikers earn 10 per mile for their favorite charities.
Click here to read more
Your donations and support make a difference.
More Resources: 
Behaviors  | 
The Alzheimer's Association is the world's leading voluntary health organization in Alzheimer's care, support and research. Our mission is to eliminate Alzheimer's disease through the advancement of research; to provide and enhance care and support for all affected; and to reduce the risk of dementia through the promotion of brain health.

Alzheimer's Association National Office 225 N. Michigan Ave., Fl. 17, Chicago, IL 60601
© 2014 Alzheimer's Association. All rights reserved. www.alz.org | 800.272.3900
To change your email preferences click here.